Christine A. White

Rituximab: the first monoclonal antibody approved for the treatment of lymphoma.

C. White, C. Varns, J. Leonard, 2000, Current pharmaceutical biotechnology.

Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity.

J. Byrd, J. Rosenberg, W. Velasquez, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Combination immunotherapy of relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma with rituximab and interferon-alpha-2a.

D. Maloney, T. Davis, S. Dowden, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Antibody-targeted immunotherapy for treatment of non-Hodgkin's lymphoma.

C. White, Judy R. Berlfein, A. Grillo‐López, 2000, Current pharmaceutical biotechnology.

Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab.

D. Maloney, W. Velasquez, R. Dillman, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical status and optimal use of rituximab for B-cell lymphomas.

D. Maloney, P. Mclaughlin, C. White, 1998, Oncology.